Researchers at the Institute for Hygiene and Biotechnology (IHB), partof the Hohenstein Institute in Bönnigheim, have developed the world's first system for assessing the efficacy of textiles and articles in everyday use against viruses. With the help of a new procedure to test antiviral effectiveness, more targeted work can now be carried out to develop products treated in this way, optimising them to meet market requirements.
MicroMol GmbH carries out microbiological, molecular and cell biological analyses, is active in research and development, performs validations and produces and sells laboratory products for the life sciences industry. This brief description reflects a broad product and service portfolio that addresses a wide range of different clients, including companies in the pharmaceutical and chemical industries and in the medical technology, industrial biotechnology and nutrition sectors.
s4s stands for ”service for success” and Tries stands for Susanne Tries, the founder of the Ehingen-based company. Since 2002, the pharmacist has been offering services to the pharmaceutical industry and in this time the company has more than lived up to its claim of “service for success”. In fact, the company’s success is now enabling it to go one step further. The company founder envisages complementing her company’s established service business with the product business, in a development that will be done step by step, with systematic dynamics and in cooperation with her husband.
GATC Biotech Europes leading sequencing service provider for industrial and academic research announces that it will open a sequencing laboratory in London to provide scientists in UK and Ireland with single sample sequencing services. The GATC London Laboratory will be situated in the London BioScience Innovation Centre LBIC and will start operations on January 4 2010.
Mediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH in Reutlingen is one of the oldest biotechnology companies in Germany. Mediagnost offers a broad range of services including the production of antibodies proteins and viruses the analysis of samples and the customisation of raw materials. The company celebrated its 25th anniversary on 19th March 2010 with a series of events.
Stuttgart-based Nexxor GmbH uses its topicWorks platform as a basis for developing “knowledge-oriented” information systems specifically for the pharmaceutical, biotech and life science sectors. These standardised software systems are no longer based solely on data and documents. They employ an innovative concept to map the meanings and semantic relationships of content in a flexible way, similar to processes used by the Semantic Web.
ChemCon GmbH, service provider for custom development and custom manufacturing of active pharmaceutical ingredients (APIs) and fine chemicals, based in the Innovationspark (innovations park) Freiburg, Germany, celebrates its 20th anniversary. On January 29 in 1997, Dr. Raphael Vogler (CEO) and Dr. Peter Gockel (CSO), both graduates from the Albert-Ludwigs-University Freiburg, signed the partnering contract to found ChemCon. Today they count 90 members of staff, and ChemCon supplies customers of the pharmaceutical and chemical industry, biotechnology companies and research institutes worldwide.
The Pap test is regarded as the most successful test for cancer ever, and has saved the lives of many women. However, the test is associated with several weaknesses. The Heidelberg-based in vitro diagnostics company mtm laboratories AG develops and commercialises highly sensitive and highly specific immunochemical tests that provide greater reliability. These tests have the potential to revolutionise the early detection of cervical cancer.
The German Cancer Research Centre and the Spanish company Chimera Pharma SL have signed an exclusive licensing and cooperation agreement. The two partners will develop a therapeutic vaccine against cervical cancer.
ColepCCL Rapid-Spray a ColepCLL subsidiary based in Laupheim Germany has made a name for itself as the largest European contract filler of aerosols. However ColepCLL which employs around 3500 people in five countries is now planning to open up new fields of activity in the life sciences area.
Opinions differ widely as to whether a bachelors degree is enough for a career in the business world. While business representatives tend to point out that bachelors graduates are most welcome in their company many students are of the opinion that a masters or doctorate degree is required. Julia Bottlang has a B. Sc. and was offered a job by Konstanz-based GATC Biotech after doing an internship there following her bachelors studies. Despite her success she believes that bachelors courses have some room for improvement.
Ulm-based varionostic helps epigenetics researchers to obtain information on gene activity. The company is specifically focused on the analysis of methyl groups (-CH3) that are attached to DNA and turn genes on and off. Just as the field of epigenetics, previously only known to insiders, has emerged as a biomedical area of research, the University of Ulm spin-off has matured and grown over the past six years since it was set up.
mtm laboratories has launched the Cervatec assay for the early diagnosis of cervical cancer. The Cervatec assay will initially be commercialized as an adjunct to the Pap test for the screening of women aged 35 and younger.
European Commission Vice President Günter Verheugen launched Enterprise Europe Network a new and powerful European support network for enterprises. All major players of the business support community in Europe have united to offer a one-stop service to assist especially small and medium sized enterprises.
Karlsruhe based quantiom bioinformatics has developed a software tool that enables the comparative analysis of chromosomes and that enables statements to be made on the correlation of genomic alterations and disease development.
As a 100% affiliate of the Baden-Württemberg government, BIOPRO Baden-Württemberg GmbH provides targeted support to the pharmaceutical industry and the biotechnology and medical technology sectors as well as supporting the development of a bioeconomy.